New COVID-19 boosters, with half the original vaccine and half protection against the BA.4 and BA.5 omicron variants, could blunt a winter surge, the Associated Press reported.
New COVID-19 boosters that target the now-dominant omicron strains are set to begin soon, after the Centers for Disease Control and Prevention endorsed the updated shots Thursday.
The new shots made by Pfizer PFE, -1.99% and German partner BioNTech BNTX, +0.06% and by rival Moderna MRNA, -0.27% offer Americans a chance to get the most up-to-date protection at yet another critical period in the pandemic. They’re combination or “bivalent” shots — half the original vaccine and half protection against the BA.4 and BA.5 omicron subvariants now causing nearly all COVID infections.
The new updated shots are only for use as a booster, not for someone’s first-ever vaccinations. The Food and Drug Administration cleared Pfizer’s bivalent option for people 12 and older, while Moderna’s is for adults only. The daily average for hospitalizations was down 9% at 37,453, while the daily average for deaths is up 8% to 513.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Long Covid: 11-year-old on Leeds long Covid clinic helpThe clinic is one of 15 regional hubs established to help children with long Covid symptoms.
Baca lebih lajut »
New COVID Omicron Boosters About to Arrive, With ControversyCOVID-19 booster vaccines targeting the Omicron BA.4 and BA.5 subvariants currently dominating in the United States could be available in the next few days, but their arrival comes with some controversy.
Baca lebih lajut »
CDC panel recommends new omicron Covid boosters with shots expected to begin next weekVaccinations are expected to start next week after CDC Director Dr. Rochelle Walensky signs off.
Baca lebih lajut »
CDC recommends Pfizer's and Moderna's new Covid boostersThe Centers for Disease Control and Prevention on Thursday signed off on updated versions of Pfizer-BioNTech’s and Moderna’s Covid boosters, allowing vaccinations to begin.
Baca lebih lajut »
COVID Incubation Shorter With Each New Variant - MedicineNet Health NewsIf you get infected with COVID-19, the time from infection to possible onset of symptoms -- the incubation period -- is significantly shorter now than it was at the beginning of the pandemic, new research shows.
Baca lebih lajut »
COVID-19 weekly update: Cases increase by 8,661, with 67 new known deathsReported COVID-19 cases in Arizona were similar to last week's numbers and the percentage of tests returning positive for the virus declined.
Baca lebih lajut »